EHS
EHS

STAT Plus: ‘An extremely volatile time’: New report underscores the recent roller coaster of the biotech market 



A new report from BIO shows just how chaotic the last few years have been for “emerging therapeutic companies” — basically, biotech companies that bring in less than $1 billion in sales.

The report, presented Tuesday at the trade organization’s annual convention, covered acquisitions, IPOs, and venture funding.

Continue to STAT Plus to read the full story…

Source link

EHS
Back to top button